Over 300 people attended the 12th Annual Conference: SCI Breast Cancer and African Americans on Saturday, August 26 in Newark, CA.

To learn more about how Stanford approaches pediatric leukemia, we spoke with Stanford Cancer Institute leader Tanja Gruber, MD.

An article published recently in the Journal of Clinical Oncology presented a case study to highlight the value of using risk-prediction models as tools for patient-clinician communication on lung cancer screening.

The Asian Liver Center continues to uphold its pledge to address the disproportionately high rates of chronic hepatitis B infection and liver cancer in Asians and Asian Americans through community outreach, academic studies, and clinical expansion.

The Stanford Cancer Institute hosted five scholars from Howard University and Morehouse College in a summer research program for medical students from Historically Black Medical Colleges.

The program provides mentorship from SCI faculty members and hands-on lab experience for Stanford undergraduates interested in exploring cancer-related career tracks.

A Stanford study published July 26 in Nature demonstrates that cancer cells can be prompted to activate cellular death, a finding that has therapeutic applications in cancer treatment, regenerative medicine, and developmental disorders. The study was led by Stanford Cancer Institute members Nathanael Gray, PhD, and Gerald Crabtree, MD.

SCI member Ruijiang Li, PhD, and colleagues have been developing a powerful approach to medical image analysis, utilizing a deep-learning program to predict treatment response and patient outcomes based on their routine CT and MRI scans, as well as digital pathology slides. .

Stanford Cancer Institute member Nam Bui, MD, sheds light on the crucial role of sarcoma centers during Sarcoma Awareness Month, offering insights into the future of sarcoma research.

The Stanford Cancer Institute (SCI) is excited to welcome new faculty member Pauline Funchain, MD, to Stanford.